Acer Therapeutics Inc. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Acer Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Acer Therapeutics Inc. Return On Equity for the quarter ending September 30, 2023 was 157 %, a 39.6% decline year-over-year.
  • Acer Therapeutics Inc. annual Return On Equity for 2022 was 219 %.
  • Acer Therapeutics Inc. annual Return On Equity for 2021 was -488 %, a 135% decline from 2020.
  • Acer Therapeutics Inc. annual Return On Equity for 2020 was -208 %, a 88.3% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 219 +708 Jan 1, 2022 Dec 31, 2022
2021 -488 -281 -135% Jan 1, 2021 Dec 31, 2021
2020 -208 -97.5 -88.3% Jan 1, 2020 Dec 31, 2020
2019 -110 -45.3 -69.7% Jan 1, 2019 Dec 31, 2019
2018 -65.1 +73.6 +53.1% Jan 1, 2018 Dec 31, 2018
2017 -139 +211 +60.3% Jan 1, 2017 Dec 31, 2017
2016 -350 -156 -80.7% Jan 1, 2016 Dec 31, 2016
2015 -193 -70.3 -57.1% Jan 1, 2015 Dec 31, 2015
2014 -123 +33 +21.1% Jan 1, 2014 Dec 31, 2014
2013 -156 +113 +42% Jan 1, 2013 Dec 31, 2013
2012 -269 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.